Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC)

Gynecologic Oncology

Volumn 108, Issue 1, 2008, Pages 201-206

  Fields, Abbie L ^a   Einstein, Mark H ^b,c   Novetsky, Akiva P ^b   Gebb, Juliana ^b   Goldberg, Gary L ^b,c  

^a Virginia Gynecologic Oncology   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

Carboplatin; Paclitaxel; Radiation therapy; Uterine cancer; Uterine papillary serous carcinoma (UPSC)

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PARAAORTIC LYMPH NODE; PATIENT COMPLIANCE; PELVIS LYMPH NODE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERUS CARCINOMA; UTERUS PAPILLARY SEROUS CARCINOMA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PILOT PROJECTS; PROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 37349112426     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.09.025     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts and Figures 2006 (2006), American Cancer Society, Atlanta
2. Hoskins W.J.P.C., Young R.C., Barakat R., Markman M., and Randall M. Principles and practice of gynecologic oncology. 4th ed. (2004), Lippincott Williams & Wilkins, Philadelphia, PA
3. Hendrickson M., Ross J., Eifel P., Martinez A., and Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6 2 (Mar 1982) 93-108
4. O'Hanlan K.A., Levine P.A., Harbatkin D., Feiner C., Goldberg G.L., Jones J.G., et al. Virulence of papillary endometrial carcinoma. Gynecol Oncol 37 1 (Apr 1990) 112-119
5. Goff B.A. Uterine papillary serous carcinoma: what have we learned over the past quarter century?. Gynecol Oncol 98 3 (Sep 2005) 341-343
6. Havrilesky L.J., Secord A.A., Bae-Jump V., Ayeni T., Calingaert B., Clarke-Pearson D.L., et al. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol 105 3 (June 2007) 677-682
7. Goff B.A., Kato D., Schmidt R.A., Ek M., Ferry J.A., Muntz H.G., et al. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 54 3 (Sep 1994) 264-268
8. Slomovitz B.M., Burke T.W., Eifel P.J., Ramondetta L.M., Silva E.G., Jhingran A., et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 91 3 (Dec 2003) 463-469
9. Randall M.E. Uterine cancer: how should patients with unusual histopathologies be managed?. A radiation oncologist's perspective. 2004 Educational Book: American Society of Clinical Oncology (2004) 309-312
10. Fleming G.F. Systemic management of endometrial cancers with unusual histology. 2004 Educational Book: American Society of Clinical Oncology (2004) 293-297
11. Hamilton C.A., Liou W.S., Osann K., Berman M.L., Husain A., Teng N.N., et al. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys 63 3 (Nov 1 2005) 839-844
12. Huh W.K., Powell M., Leath III C.A., Straughn Jr. J.M., Cohn D.E., Gold M.A., et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy. Gynecol Oncol 91 3 (Dec 2003) 470-475
13. Mehta N., Yamada S.D., Rotmensch J., and Mundt A.J. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 57 4 (Nov 15 2003) 1004-1009
14. Sutton G., Axelrod J.H., Bundy B.N., Roy T., Homesley H., Lee R.B., et al. Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 100 2 (Feb 2006) 349-354
15. Sutton G., Axelrod J.H., Bundy B.N., Roy T., Homesley H.D., Malfetano J.H., et al. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study. Gynecol Oncol 97 3 (Jun 2005) 755-763
16. Randall M.E., Filiaci V.L., Muss H., Spirtos N.M., Mannel R.S., Fowler J., et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24 1 (Jan 1 2006) 36-44
17. Zanotti K.M., Belinson J.L., Kennedy A.W., Webster K.D., and Markman M. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. Gynecol Oncol 74 2 (Aug 1999) 272-277
18. Fleming G.F., Brunetto V.L., Cella D., Look K.Y., Reid G.C., Munkarah A.R., et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 22 11 (Jun 1 2004) 2159-2166
19. Kelly M.G., O'Malley D., Hui P., McAlpine J., Dziura J., Rutherford T.J., et al. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecol Oncol 95 3 (Dec 2004) 469-473
20. Elit L., Kwon J., Bentley J., Trim K., Ackerman I., and Carey M. Optimal management for surgically Stage 1 serous cancer of the uterus. Gynecol Oncol 92 1 (Jan 2004) 240-246
21. Duska L.R., Berkowitz R., Matulonis U., Muto M., Goodman A., McIntyre J.F., et al. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Gynecol Oncol 96 1 (Jan 2005) 198-203
22. Low J.S., Wong E.H., Tan H.S., Yap S.P., Chua E.J., Sethi V.K., et al. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma. Gynecol Oncol 97 1 (Apr 2005) 171-177
23. Chan J.K., Loizzi V., Youssef M., Osann K., Rutgers J., Vasilev S.A., et al. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol 90 1 (Jul 2003) 181-185
24. Gehrig P.A., Van Le L., and Fowler Jr. W.C. The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer 13 2 (Mar-Apr 2003) 212-215